Psychedelic Healing - a Vulnerable Conversation with Daniel and Danielle

A conversation on Psychedelic Healing with Daniel (they/he/she) @manosdelmaya on IG!  https://www.instagram.com/manosdelmaya/ 

Daniel, thank you for bringing your wisdom to this conversation! You're the only human I could consider having this discussion with publicly! 

The Context: 

Psychedelic Healing Converstation Preamble 

In preparation for tomorrow's conversation, I wanted to share some of the resources I studied in 2020 + 2021 around using psychedelic healing in an effort tp manage and potentially treat my PMDD. 

Tomorrow instead of providing this research live, I want to use our time to share about my experiences, and bring a true subject matter expert on the topic 🌻✨ Daniel, Mayan Mystic 🛸 (he/she) I did over a year of studying on the topic, consulting with my physician and therapist in preparation for my own experiences in late 2021 and again in early 2022.  I wanted to 'dump' here some of the insights that interested me in my research.

My biggest concern was the potential negative affect a Psychedelic would have on my ability to connect with the Spirit World, I have never wanted to risk my connection with Spirit, so I was very comforted to find the research of Psychic Medium Eileen Garret (best known for her book 'Awareness') 

Some resources: 

Eileen Garrett's Work on Psychic Exploration:

• Eileen Garrett's organization stands as a cornerstone in parapsychology and spiritual exploration, focusing on the intersection between altered states of consciousness, psychic phenomena, and the impact of substances like LSD on enhancing psychic experiences The Parapsychology Foundation: This organization preserves and shares information related to parapsychology, including Eileen Garrett's work and research. Parapsychology Foundation

• https://parapsychology.org/the-many-minds-of-eileen-garrett/

• https://psi-encyclopedia.spr.ac.uk/articles/eileen-j-garrett 

• https://chacruna.net/eileen-garrett-and-psychedelic-experience/ 

• You can use duckduckgo to find more articles, I found google to bury articles like this

I discovered about Psilocybin and healing through my death doula continuing studies + research that John Hopkins University was testing high-dose Psilocybin on patients with death-anxiety in terminal illness, the results were incredible, and that really sparked my initial interest in the topic, a bit more resources and about John Hopkins Psychedelic Research: 

Johns Hopkins Research Center is a pioneering institution renowned for its groundbreaking studies exploring the therapeutic potential of psychedelics, particularly psilocybin, in treating various mental health conditions.

• https://hopkinspsychedelic.org/index/#research Honestly this site will keep you busy for a long time!

Johns Hopkins University Research Data Revealed:

• Smoking Cessation Success Rate: One of the most notable findings is the high success rate in smoking cessation post-psilocybin therapy. Research indicated an astonishing 85% success rate in helping individuals quit smoking, far surpassing traditional methods. As someone who abused colonized tobacco for 17 years, I wish I knew this in 2002! 

• Reduction in Anxiety and Depression Scores: Psilocybin therapy demonstrated substantial reductions in anxiety and depression scores among participants. These improvements were observed in both immediate and long-term assessments following the therapy sessions.

• Long-Term Positive Effects: Data showcased enduring positive effects, indicating sustained improvements in emotional well-being and increased quality of life among participants even after the therapy sessions had concluded.

• End-of-Life Distress Alleviation: The studies revealed the profound impact of psilocybin therapy on end-of-life distress in terminally ill patients. Participants experienced a significant reduction in anxiety and increased feelings of peace and acceptance, easing their distress about death.

• Safety Profile: The data reinforced the safety profile of psilocybin therapy when administered in controlled, clinical settings with trained professionals. Mini